Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page history shows a new revision v3.3.2 was added and the previous v3.3.1 removed, reflecting a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision: v3.3.1 appears in the page footer, replacing v3.2.0. This is a minor version update and does not affect study information or page functionality.SummaryDifference0.0%

- Check43 days agoChange DetectedThe banner about government funding/operating status in the page header was removed.SummaryDifference0.3%

- Check57 days agoChange DetectedThe record history shows multiple updates to the study status, recruitment status, and contacts/locations across several versions. These changes reflect ongoing progress and adjustments to site availability and contact information.SummaryDifference0.0%

- Check86 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference9%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.